Thank you to our Sponsors
Giving emerging companies that
Big Company Advantage...
The BioCenter is an incubator providing a new generation of facilities, specialized equipment, world class laboratory and business support services. Our mission is to provide entrepreneurs with that "Big Company Advantage" through facilities, equipment, resources, contacts and expertise they need to commercialize their technology. The recent addition of over $5M in state of the art Core Lab - including a Chemistry Analytics Lab, a Biology Lab, and three Tissue Culture Rooms - has completed our evolution as the destination location for Bioconvergence companies and research scientists alike.
Subscribe to BioCenter Announcements
Email:
Announcements

The California Center for Healthcare and Biomedical Technology Hospital | a center of excellence dedicated to high quality, comprehensive biomedical research and patient treatment, will break ground this year.

BioCenter Expansion: Reserve Your Lab Now! The BioCenter recently kicked off the expansion to 80,000sf with second stage lab spaces of 5,000 – 10,000 sf. Applications to reserve lab spaces are now available.

Phase I/II contract biomanufacturing facility | project is underway.

Getting to the BioCenter Just Got Easier | a free shuttle service delivers employees from the San Jose Diridon train station and Cottle lightrail station to the BioCenter.

25% Off on Specialized CORE Lab Trainings | For a limited time only, the BioCenter is offering 25% off on specialized Varian Trainings, including: NMR System Manager, NMR Automation, and HPLC Techniques & Troubleshooting.




Upcoming BioCenter Events

May 13, 2008
BioBriefing

May 22, 2008 - 3pm-6:30pm
Financing Alternatives: Where’s the Money??

September 18, 2008 - 3pm-6:30pm
Overcoming M&A Challenges - Planning a Good Deal, Planning Your Exit

December 11, 2008 - 3pm-6:30pm
BioCenter Holiday Celebration & Trends In Financing Investor Panel



Latest News

May 1, 2008
Aridis Announces Positive Shelf-Life Results from Vaccine Dehydration Testing
- Press Release

May 1, 2008
Clean Tech Open finds next big green idea
- ABC News

April 21, 2008
EnWave Corporation Provides Update on Development and Commercialization of Novel Dehydration Technology - bioREV: Aridis Testing Moves Forward
- Press Release

April 16, 2008
Solar Power Play - Mayor Reed puts some political muscle behind his vision with a push to make green building mandatory
- Metro Newspapers

April 11, 2008
S.J. mayor's solar challenge
- San Jose Mercury News

April 10, 2008
Cali Cleantech Open Launches, Mayor Issues Challenge
- Earth2Tech

April 10, 2008
San Jose mayor urges solar companies to do free residential installations
- Silicon Valley/San Jose Business Journal

April 9, 2008
Clean Tech Open Launches USA's Richest Clean Tech Business Competition
- Press Release

April 6, 2008
San Jose Sponsors Third Annual Clean Tech Open
- CleanBeta

April 4, 2008
Cleantech entrepreneur competition relocates to San Jose
- Silicon Valley/San Jose Business Journal

April 2, 2008
San Jose Mayor Launches "Academy Awards" of the Clean Tech Industry
- Press Release

March 31, 2008
BioMarker Launches Gene Essence™ DNA Test
- Press Release

March 21, 2008
Builders buy into life sciences
- Silicon Valley/San Jose Business Journal

March 12, 2008
Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement To Develop and Commercialize RNAi Hepatitis C Drug
- Press Release

March 7, 2008
Aridis Pharma seeks $10M for oral-form drugs and vaccines
- VentureBeat LifeScience

March 6, 2008
Startups To Watch: Theraject
- StartupsToWatch

March 6, 2008
EnWave Provides Progress Report on Aridis Collaboration Testing of Vaccine Dehydration Technology
- Press Release

February, 2008
Dissolvable Microneedle Patch for Biopharmaceuticals Delivery and Vaccination
- Drug Delivery Report

January 11, 2008
Deals of the Week: far from the Westin St. Francis
- The IN VIVO Blog

January 8, 2008
Tacere's shRNA Drug for HCV Subject of $145M Pfizer Deal
- BioWorld Today

January 7, 2008
Tacere could get more than $145M in hepatitis drug deal with Pfizer
- Silicon Valley/San Jose Business Journal

January 7, 2008
Tacere Therapeutics strikes RNAi deal with Pfizer for up to $145M
- VentureBeat

January 7, 2008
Pfizer and Tacere Enter HCV Deal Worth over $145M
- Genetic Engineering News

January 7, 2008
Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
- Press Release

November 12, 2007
Dinheiro e tecnologia - The City of San Jose and the BioCenter attract talents and stimulate research of high level
- Globo TV

© San Jose BioCenter, All Rights Reserved. | info@sjbiocenter.com